Cart
sales@molnova.com
GR-64349
CAS No. 137593-52-3
GR-64349 ( GR64349 )
Catalog No. M11556 CAS No. 137593-52-3
GR-64349 is a potent and selective tachykinin NK2 receptor agonist with EC50 of 3.7 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGR-64349
-
NoteResearch use only, not for human use.
-
Brief DescriptionGR-64349 is a potent and selective tachykinin NK2 receptor agonist with EC50 of 3.7 nM.
-
DescriptionGR-64349 is a potent and selective tachykinin NK2 receptor agonist with EC50 of 3.7 nM, displays >1000- and >300-fold selectivity over NK1 and NK3 receptors, respectively.Pain Discontinued
-
SynonymsGR64349
-
PathwayGPCR/G Protein
-
TargetNeurokinin Receptor
-
RecptorNeurokinin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number137593-52-3
-
Formula Weight921.12
-
Molecular FormulaC42H68N10O11S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CC(C(=O)NC(CCSC)C(=O)N)N1CCC(C1=O)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)N
-
Chemical NameKDSFVGLM (Modifications: Leu-7 = R-γ-lactam-Leu, Met-8 = C-terminal amide)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Deal MJ, et al. J Med Chem. 1992 Oct 30;35(22):4195-204.
2. Chizh BA, et al. Br J Pharmacol. 1995 Jul;115(6):1013-9.
3. Chang Y, et al. J Pharmacol Exp Ther. 2000 Jul;294(1):147-54.
2. Chizh BA, et al. Br J Pharmacol. 1995 Jul;115(6):1013-9.
3. Chang Y, et al. J Pharmacol Exp Ther. 2000 Jul;294(1):147-54.
molnova catalog
related products
-
GR-64349
GR-64349 is a potent and selective tachykinin NK2 receptor agonist with EC50 of 3.7 nM.
-
Neurokinin A(4-10)(T...
Neurokinin A(4-10)(TFA) is an agonist of tachykinin NK2 receptor .
-
Maropitant
Maropitant is a selective neurokinin (NK1) receptor antagonist.
